Evogene rises after its US IPO raises $73.8M

NEW YORK (AP) - Shares of Evogene climbed in morning trading after the biotechnology company said it raised $73.8 million through its U.S. initial public offering.

Evogene's offering of 5 million shares priced at $14.75 per share. Agribusiness giant Monsanto Co. is paying $12 million for 814,000 shares.

Evogene shares gained $1.30, or 8.8 percent, to $16.05. Earlier the stock rose to $18.10.

The shares are trading on the New York Stock Exchange under the ticker symbol "EVGN."

Evogene Ltd. is based in Rehovot, Israel, and focuses on developing new traits to insert into commercial crops such as corn and soybeans.

The underwriters of the IPO will have the option to buy another 750,000 shares to cover over allotments. Monsanto will own 9.4 percent of the company if those shares are sold.

(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

Top Stories

  • Trial Beginning
    Twelve Seattle police officers will begin using new body-worn cameras next week

  • Week in Photos
    Penguins, cheetahs and Santa make it in this week's photos
ATTENTION COMMENTERS: We've changed our comments, but want to keep you in the conversation.
Please login below with your Facebook, Twitter, Google+ or Disqus account. Existing MyNorthwest account holders will need to create a new Disqus account or use one of the social logins provided below. Thank you.
comments powered by Disqus
Sign up for breaking news e-mail alerts from MyNorthwest.com
In the community
Do you know an exceptional citizen who has impacted and inspired others?
KIRO Radio and WSECU would like to recognize six oustanding citizens this year. Nominate them to be recognized and to receive a $2,000 charitable grant.